Robert J Motzer Selected Research

Robert J Motzer Research Topics

Disease

252	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 01/2002
134	Neoplasms (Cancer) 04/2024 - 01/2002
39	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 09/2023 - 11/2002
25	Fatigue 04/2023 - 01/2007
21	Kidney Neoplasms (Kidney Cancer) 04/2024 - 08/2004
21	Disease Progression 11/2023 - 01/2002
19	Neoplasm Metastasis (Metastasis) 01/2024 - 11/2003
19	Hypertension (High Blood Pressure) 04/2023 - 11/2007
14	Teratoma (Teratoid Tumor) 10/2019 - 10/2003
11	Testicular Neoplasms (Testicular Cancer) 09/2016 - 11/2003
8	Diarrhea 04/2023 - 01/2007
8	Hypoxia (Hypoxemia) 02/2018 - 12/2006
7	Exanthema (Rash) 10/2019 - 05/2007
6	Hand-Foot Syndrome 04/2023 - 10/2008
5	Stomatitis 01/2020 - 09/2007
5	Nonseminomatous germ cell tumor 08/2018 - 02/2004
4	Body Weight (Weight, Body) 05/2023 - 11/2015
4	Dyspnea (Shortness of Breath) 10/2018 - 06/2008
4	Hyperglycemia 10/2016 - 05/2007
4	Thrombocytopenia (Thrombopenia) 10/2016 - 01/2009
4	Neutropenia 12/2015 - 06/2006
3	Necrosis 01/2023 - 07/2011
3	Tics (Tic) 01/2021 - 10/2015
3	Fibrosis (Cirrhosis) 01/2019 - 01/2002
3	Anemia 07/2017 - 06/2006
3	Embryonal Carcinoma 01/2017 - 10/2003
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017 - 07/2010
3	Edema (Dropsy) 12/2015 - 05/2007
3	Asthenia 12/2015 - 05/2007
3	Carcinoma (Carcinomatosis) 02/2015 - 01/2011
3	Clear-cell metastatic renal cell carcinoma 03/2014 - 05/2013
3	Seminoma 11/2003 - 01/2002
2	Inflammation (Inflammations) 10/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 10/2020
2	Carcinogenesis 01/2019 - 03/2008
2	Nausea 10/2018 - 09/2007
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2017 - 03/2011

Drug/Important Bio-Agent (IBA)

108	Sunitinib (Sutent)FDA Link 04/2024 - 01/2006
47	Everolimus FDA Link 01/2022 - 12/2006
41	NivolumabIBA 01/2024 - 05/2015
39	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024 - 08/2005
33	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2002
32	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2016
23	IpilimumabIBA 01/2024 - 04/2018
21	Tyrosine Kinase InhibitorsIBA 03/2023 - 05/2006
20	Interferon-alpha (Interferon Alfa)IBA 04/2023 - 01/2002
19	cabozantinibIBA 08/2023 - 11/2015
18	Axitinib (AG 013736)IBA 03/2024 - 11/2007
17	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 01/2006
17	Bevacizumab (Avastin)FDA Link 02/2022 - 12/2006
15	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2002
14	pazopanib FDA Link 01/2021 - 08/2013
13	TOR Serine-Threonine KinasesIBA 01/2019 - 09/2007
12	lenvatinibIBA 04/2024 - 11/2015
12	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2002
12	Sorafenib (BAY 43-9006)FDA Link 08/2015 - 12/2006
11	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 12/2010
10	InterferonsIBA 02/2016 - 04/2007
9	CytokinesIBA 01/2018 - 09/2004
8	atezolizumabIBA 02/2022 - 01/2018
8	temsirolimus FDA Link 10/2014 - 12/2006
7	avelumabIBA 02/2024 - 01/2019
6	pembrolizumabIBA 04/2024 - 03/2019
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2007
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 09/2005
5	B7-H1 AntigenIBA 01/2022 - 01/2019
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2002
5	PlatinumIBA 10/2019 - 01/2002
5	Ifosfamide FDA LinkGeneric 01/2016 - 09/2005
5	MTOR InhibitorsIBA 04/2014 - 08/2010
4	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 01/2007
4	LigandsIBA 02/2022 - 03/2016
4	Hemoglobins (Hemoglobin)IBA 06/2017 - 10/2006
4	Tumor Biomarkers (Tumor Markers)IBA 10/2014 - 10/2007
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 01/2006
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2010
3	Lipase (Acid Lipase)FDA Link 10/2019 - 06/2006
3	Interleukin-2 (IL2)IBA 12/2017 - 08/2008
3	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 05/2006
3	Alkaline PhosphataseIBA 01/2015 - 10/2006
3	Carbonic Anhydrase IXIBA 10/2014 - 04/2007
2	Programmed Cell Death 1 ReceptorIBA 01/2024 - 02/2018
2	Fumarate Hydratase (Fumarase)IBA 11/2023 - 01/2021
2	MicroRNAs (MicroRNA)IBA 06/2020 - 12/2010
2	Alanine Transaminase (SGPT)IBA 10/2019 - 08/2013
2	Amylases FDA Link 10/2019 - 12/2015
2	NucleotidesIBA 01/2019 - 02/2016
2	Phosphotransferases (Kinase)IBA 10/2018 - 05/2006

Therapy/Procedure

146	Therapeutics 03/2024 - 01/2002
42	Drug Therapy (Chemotherapy) 11/2023 - 01/2002
33	Nephrectomy 01/2024 - 12/2002
23	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 11/2002
17	Immunotherapy 04/2024 - 01/2016
6	Aftercare (After-Treatment) 01/2021 - 06/2003
6	Adjuvant Chemotherapy 01/2020 - 11/2002
4	Salvage Therapy 02/2016 - 01/2007
3	Drug Tapering 03/2015 - 08/2010
3	Radiotherapy 02/2015 - 11/2003
2	Duration of Therapy 10/2016 - 02/2016